School of Pharmacy

Strategic plan progress report. Research: Driving the development of innovative and precise drugs, medical devices, and diagnostic tests. Flu treatments; Tackling antimalarial resistance; Attacking hard targets; Plotting cell maps; Safer opioid pain killer; Cellular construction; New products...

Big Pharma and Big Biotech in the Bay Area

No pre-registration is required.

Questions?

[email protected]

Session chairs

Daniel V. Santi, MD, PhD

Professor and Associate Dean
UCSF School of Pharmacy;
Co-founder, ProLynx

Kathy Giacomini, PhD, a leader in the field of pharmacogenomics, has been named the 2017 recipient of the North American Scientific Achievement Award, presented by the International Society for the Study of Xenobiotics (ISSX).

The common lab practice of adding antibiotics to cell cultures to prevent contamination can actually induce genetic changes in the cells, a paper senior-authored by Nadav Ahituv, PhD, found. Ahituv is a faculty member in the Department of Bioengineering and Therapeutic Sciences, a joint department...

Ching C. Wang, PhD, a beloved UCSF School of Pharmacy researcher and professor, known for bringing molecular biology and biochemistry to parasitology, and for his work on the antiparasitic medicine ivermectin, died last week at the age of 80.

To his wide circle of colleagues and friends, he was...